These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 728352)

  • 21. The anticancer spectrum of ifosfamide.
    Hunter HL; Harrison EF
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):96-100. PubMed ID: 6761868
    [No Abstract]   [Full Text] [Related]  

  • 22. [Chemotherapeutic activity of ifosfamide in 6 different isologously transplanted experimental tumours of BD-rats (author's transl)].
    Stekar J
    Arzneimittelforschung; 1976; 26(10):1793-7. PubMed ID: 191035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor activity evaluation of bromine-substituted analogues of ifosfamide. I. Stereodifferentiation of biological effects and selection of the most potent compounds.
    Glazman-Kuśnierczyk H; Matuszyk J; Radzikowski C
    Immunopharmacol Immunotoxicol; 1992; 14(4):883-911. PubMed ID: 1294626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combined cytostatic chemotherapy of advanced non-small-cell bronchial carcinoma with doxorubicin and ifosfamide].
    Matthiessen W; Stempinski E; Göbel D; Thalmann U
    Dtsch Med Wochenschr; 1983 May; 108(21):810-5. PubMed ID: 6851871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
    Mayo JG; Laster WR; Andrews CM; Schabel FM
    Cancer Chemother Rep; 1972 Apr; 56(2):183-95. PubMed ID: 5043226
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of micrometastases from Lewis lung carcinoma with abrin and cyclophosphamide, given singly and in combination.
    Gundersen S; Fodstad O
    Int J Cancer; 1979 Apr; 23(4):530-5. PubMed ID: 437927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of ifosfamide in the polychemotherapy of metastasized testicular cancer pretreated with chemotherapy.
    Clemm C; Hartenstein R; Wilmanns W
    Arzneimittelforschung; 1982; 32(12):1557-60. PubMed ID: 6891596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ifosfamide in comparison with cyclophosphamide in advanced ovarian carcinomas (author's transl)].
    Teufel G; Pfleiderer A
    Geburtshilfe Frauenheilkd; 1976 Mar; 36(3):274-9. PubMed ID: 1261795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II chemotherapy trials of 5-FU, cyclophosphamide, ifosfamide, and vincristine in carcinoma of the bilharzial bladder.
    Gad-el-Mawla N; Ziegler JL; Hamza R; Elserafi M; Khaled H
    Cancer Treat Rep; 1984 Feb; 68(2):419-21. PubMed ID: 6697330
    [No Abstract]   [Full Text] [Related]  

  • 30. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN; Miloushev AS
    Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The bioavailability of oral and intravenous ifosfamide in the treatment of bronchogenic carcinoma.
    McNiel NO; Morgan LR
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):490-3. PubMed ID: 7298241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A quantitative model for the study of the growth and treatment of a tumor and its metastases with correlation between proliferative state and sensitivity to cyclophosphamide.
    DeWys WD
    Cancer Res; 1972 Feb; 32(2):367-73. PubMed ID: 5058192
    [No Abstract]   [Full Text] [Related]  

  • 33. Control of Lewis lung carcinoma by combined treatment with local hyperthermia and cyclophosphamide: preliminary results.
    Yerushalmi A; Hazan G
    Isr J Med Sci; 1979 May; 15(5):462-3. PubMed ID: 447517
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
    Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS
    Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem-cell survival and tumor control in the Lewis lung carcinoma.
    Steel GG; Adams K
    Cancer Res; 1975 Jun; 35(6):1530-5. PubMed ID: 1169108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical experiences with holoxan within the framework of sequential combination therapy (author's transl)].
    Hartwich G; Neidhardt B; Lutz H
    Med Klin; 1978 Sep; 73(36):1247-52. PubMed ID: 692477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ifosfamide versus cyclophosphamide in combination drug therapy for metastatic breast cancer.
    Buzdar AU; Legha SS; Tashima CK; Yap HY; Hortobagyi GN; Hersh EM; Blumenschein GR; Bodey GP
    Cancer Treat Rep; 1979 Jan; 63(1):115-20. PubMed ID: 369682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical evaluation of toxicity and therapeutic efficacy of a stabilized cytostatic metabolite of cyclophosphamide (ASTA Z 7557, INN mafosfamide).
    Klein HO; Wickramanayake PD; Christian E; Coerper C
    Invest New Drugs; 1984; 2(2):191-9. PubMed ID: 6469514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of metastatic osteosarcoma by cyclophosphamide and radiotherapy.
    Schaeffer J; el-Mahdi AM; Constable WC
    Radiology; 1974 May; 111(2):467-9. PubMed ID: 4522475
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative cytotoxic properties of ifosfamide and cyclophosphamide in rat solid tumor and normal tissues.
    Tew KD
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):24-7. PubMed ID: 7163812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.